Financial Counselors Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-126,429
| Closed | -$7.71M | – | 70 |
|
|
2025
Q1 | $7.71M | Sell |
126,429
-6,033
| -5% | -$352K | 0.12% | 162 |
|
|
2024
Q4 | $7.49M | Sell |
132,462
-2,115
| -2% | -$118K | 0.11% | 167 |
|
|
2024
Q3 | $6.96M | Sell |
134,577
-5,321
| -4% | -$250K | 0.1% | 166 |
|
|
2024
Q2 | $5.81M | Sell |
139,898
-5,895
| -4% | -$264K | 0.09% | 176 |
|
|
2024
Q1 | $7.91M | Sell |
145,793
-3,052
| -2% | -$155K | 0.13% | 152 |
|
|
2023
Q4 | $7.64M | Sell |
148,845
-3,386
| -2% | -$178K | 0.14% | 152 |
|
|
2023
Q3 | $8.84M | Buy |
152,231
+294
| +0.2% | +$18K | 0.18% | 134 |
|
|
2023
Q2 | $9.72M | Sell |
151,937
-3,298
| -2% | -$221K | 0.2% | 125 |
|
|
2023
Q1 | $10.8M | Sell |
155,235
-298
| -0.2% | -$21K | 0.23% | 114 |
|
|
2022
Q4 | $11.2M | Sell |
155,533
-2,079
| -1% | -$157K | 0.25% | 109 |
|
|
2022
Q3 | $11.2M | Sell |
157,612
-6,079
| -4% | -$441K | 0.28% | 103 |
|
|
2022
Q2 | $12.6M | Buy |
163,691
+9,690
| +6% | +$738K | 0.29% | 101 |
|
|
2022
Q1 | $11.2M | Buy |
154,001
+2,071
| +1% | +$139K | 0.23% | 115 |
|
|
2021
Q4 | $9.47M | Sell |
151,930
-18,338
| -11% | -$1.08M | 0.19% | 135 |
|
|
2021
Q3 | $10.1M | Sell |
170,268
-3,378
| -2% | -$222K | 0.22% | 126 |
|
|
2021
Q2 | $11.6M | Sell |
173,646
-3,080
| -2% | -$201K | 0.25% | 116 |
|
|
2021
Q1 | $11.2M | Buy |
176,726
+444
| +0.3% | +$27.6K | 0.26% | 112 |
|
|
2020
Q4 | $10.9M | Sell |
176,282
-3,382
| -2% | -$208K | 0.27% | 104 |
|
|
2020
Q3 | $10.8M | Sell |
179,664
-7,828
| -4% | -$471K | 0.32% | 91 |
|
|
2020
Q2 | $11M | Buy |
187,492
+21,499
| +13% | +$1.29M | 0.35% | 88 |
|
|
2020
Q1 | $9.25M | Sell |
165,993
-2,242
| -1% | -$137K | 0.41% | 81 |
|
|
2019
Q4 | $10.8M | Buy |
168,235
+13,916
| +9% | +$797K | 0.38% | 85 |
|
|
2019
Q3 | $7.83M | Buy |
154,319
+2,993
| +2% | +$141K | 0.31% | 105 |
|
|
2019
Q2 | $6.86M | Sell |
151,326
-1,411
| -0.9% | -$65.7K | 0.28% | 120 |
|
|
2019
Q1 | $7.29M | Sell |
152,737
-3,992
| -3% | -$199K | 0.31% | 108 |
|
|
2018
Q4 | $8.15M | Sell |
156,729
-4,185
| -3% | -$225K | 0.4% | 77 |
|
|
2018
Q3 | $9.99M | Sell |
160,914
-4,390
| -3% | -$261K | 0.44% | 76 |
|
|
2018
Q2 | $9.15M | Sell |
165,304
-18,361
| -10% | -$992K | 0.42% | 77 |
|
|
2018
Q1 | $11.6M | Sell |
183,665
-323
| -0.2% | -$20.8K | 0.55% | 56 |
|
|
2017
Q4 | $11.3M | Buy |
183,988
+15
| +0% | +$938 | 0.52% | 61 |
|
|
2017
Q3 | $11.7M | Buy |
183,973
+15,730
| +9% | +$918K | 0.57% | 55 |
|
|
2017
Q2 | $9.37M | Buy |
168,243
+49,345
| +42% | +$2.69M | 0.47% | 71 |
|
|
2017
Q1 | $6.47M | Sell |
118,898
-1,064
| -0.9% | -$58.4K | 0.33% | 104 |
|
|
2016
Q4 | $7.01M | Buy |
+119,962
| New | +$6.56M | 0.37% | 86 |
|
|
2016
Q2 | $8.21M | Buy |
111,677
+34
| +0% | +$2.4K | 0.49% | 65 |
|
|
2016
Q1 | $7.13M | Sell |
111,643
-464
| -0.4% | -$29.3K | 0.44% | 75 |
|
|
2015
Q4 | $7.71M | Sell |
112,107
-2,935
| -3% | -$194K | 0.5% | 61 |
|
|
2015
Q3 | $6.81M | Sell |
115,042
-4,822
| -4% | -$306K | 0.47% | 68 |
|
|
2015
Q2 | $7.98M | Buy |
119,864
+7,656
| +7% | +$505K | 0.51% | 59 |
|
|
2015
Q1 | $7.24M | Sell |
112,208
-32,245
| -22% | -$2.02M | 0.45% | 71 |
|
|
2014
Q4 | $8.53M | Sell |
144,453
-5,171
| -3% | -$292K | 0.54% | 53 |
|
|
2014
Q3 | $7.66M | Buy |
149,624
+8,289
| +6% | +$414K | 0.54% | 53 |
|
|
2014
Q2 | $6.86M | Sell |
141,335
-7,456
| -5% | -$367K | 0.48% | 65 |
|
|
2014
Q1 | $7.73M | Sell |
148,791
-5,825
| -4% | -$310K | 0.56% | 49 |
|
|
2013
Q4 | $8.22M | Sell |
154,616
-64,664
| -29% | -$3.29M | 0.62% | 46 |
|
|
2013
Q3 | $10.1M | Sell |
219,280
-6,017
| -3% | -$264K | 0.84% | 30 |
|
|
2013
Q2 | $10.1M | Buy |
+225,297
| New | +$9.78M | 0.84% | 31 |
|
Other funds holding BMY
Financial Counselors Inc's BMY Position: Q2 2025 in Review
Financial Counselors Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 126,429 shares — an estimated $7.71M sold.
Financial Counselors Inc first reported a position in BMY in Q2 2013 and held it in 47 quarters. The position peaked at $12.6M in Q2 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Financial Counselors Inc reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- Financial Counselors Inc sold 126,429 Bristol-Myers Squibb shares in Q2 2025, an estimated $7.71M.
- Financial Counselors Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 47 quarters.
- Financial Counselors Inc's Bristol-Myers Squibb position peaked at $12.6M in Q2 2022.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.